Aims and Scope of Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy is a peer-reviewed scientific journal published by the American Society for Microbiology. It covers antimicrobial, antiviral, antifungal, and antiparasitic agents and chemotherapy. The editor-in-chief is Cesar A. Arias (University of Texas Health Science Center at Houston). It was established in 1972 by Gladys Lounsbury Hobby. Less
Key Metrics
CiteScore 

9.3
Impact Factor 

< 5
Scite Index 

0.89 5-Year SI

SJR 

Q1Pharmacology

SNIP 

1.4
Recommended pre-submission checks
Powered by 

Topics Covered on Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy Journal Specifications
| Overview | |
| Publisher | AMER SOC MICROBIOLOGY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1953 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Antimicrobial Agents and Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Antimicrobial Agents and Chemotherapy
Targeting reactivated toxoplasmosis: therapeutic efficacy of the green-synthesized copper nanoparticles combined with pyrimethamine.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Achieving therapeutic antibiotic levels during intermittent dosing of meropenem and piperacillin-tazobactam in critically ill children: the ATACC study.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Solving the degradation problem of continuous ceftazidime infusions-the Cooltaz study.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Pralatrexate is a potent pan-serotype human adenovirus inhibitor through suppression of dihydrofolate reductase.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Targeting reactivated toxoplasmosis: therapeutic efficacy of the green-synthesized copper nanoparticles combined with pyrimethamine.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Achieving therapeutic antibiotic levels during intermittent dosing of meropenem and piperacillin-tazobactam in critically ill children: the ATACC study.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Solving the degradation problem of continuous ceftazidime infusions-the Cooltaz study.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy
Pralatrexate is a potent pan-serotype human adenovirus inhibitor through suppression of dihydrofolate reductase.
- 1 Jul 2026
- Antimicrobial agents and chemotherapy